vs
费森尤斯医疗（FMS）与Quipt Home Medical Corp.（QIPT）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是Quipt Home Medical Corp.的111.7倍（$5.5B vs $49.0M）。费森尤斯医疗净利率更高（7.9% vs -2.1%，领先10.1%）。Quipt Home Medical Corp.同比增速更快（32.3% vs -0.3%）
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
Quipt Home Medical Corp是一家总部位于美国的家用医疗设备服务商，主营呼吸护理、睡眠治疗用品及慢性病管理相关医疗产品，面向慢性病患者群体提供服务，合作方涵盖医疗机构与保险支付机构。
FMS vs QIPT — 直观对比
营收规模更大
FMS
是对方的111.7倍
$49.0M
营收增速更快
QIPT
高出32.5%
-0.3%
净利率更高
FMS
高出10.1%
-2.1%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $5.5B | $49.0M |
| 净利润 | $434.2M | $-1.1M |
| 毛利率 | 27.4% | 53.5% |
| 营业利润率 | 11.7% | 2.1% |
| 净利率 | 7.9% | -2.1% |
| 营收同比 | -0.3% | 32.3% |
| 净利润同比 | 240.4% | 2.9% |
| 每股收益（稀释后） | — | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMSQIPT
| Q4 25 | $5.5B | $49.0M | ||
| Q3 25 | — | $39.8M | ||
| Q2 25 | — | $35.1M | ||
| Q1 25 | — | $33.3M | ||
| Q4 24 | $5.5B | $37.1M |
净利润FMSQIPT
| Q4 25 | $434.2M | $-1.1M | ||
| Q3 25 | — | $-3.5M | ||
| Q2 25 | — | $-3.0M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 24 | $127.6M | $-1.1M |
毛利率FMSQIPT
| Q4 25 | 27.4% | 53.5% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | — | 57.6% | ||
| Q1 25 | — | 54.6% | ||
| Q4 24 | 25.0% | 52.1% |
营业利润率FMSQIPT
| Q4 25 | 11.7% | 2.1% | ||
| Q3 25 | — | -3.6% | ||
| Q2 25 | — | -5.2% | ||
| Q1 25 | — | -3.0% | ||
| Q4 24 | 5.1% | 1.2% |
净利率FMSQIPT
| Q4 25 | 7.9% | -2.1% | ||
| Q3 25 | — | -8.9% | ||
| Q2 25 | — | -8.6% | ||
| Q1 25 | — | -9.1% | ||
| Q4 24 | 2.3% | -2.9% |
每股收益（稀释后）FMSQIPT
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $10.5M |
| 总债务越低越好 | — | $84.0M |
| 股东权益账面价值 | $15.4B | $113.0M |
| 总资产 | $33.5B | $280.7M |
| 负债/权益比越低杠杆越低 | — | 0.74× |
8季度趋势，按日历期对齐
现金及短期投资FMSQIPT
| Q4 25 | $1.7B | $10.5M | ||
| Q3 25 | — | $12.9M | ||
| Q2 25 | — | $11.3M | ||
| Q1 25 | — | $17.1M | ||
| Q4 24 | $1.3B | $15.5M |
总债务FMSQIPT
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | — | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M |
股东权益FMSQIPT
| Q4 25 | $15.4B | $113.0M | ||
| Q3 25 | — | $112.1M | ||
| Q2 25 | — | $102.5M | ||
| Q1 25 | — | $103.6M | ||
| Q4 24 | $17.0B | $106.3M |
总资产FMSQIPT
| Q4 25 | $33.5B | $280.7M | ||
| Q3 25 | — | $283.3M | ||
| Q2 25 | — | $236.1M | ||
| Q1 25 | — | $244.6M | ||
| Q4 24 | $36.3B | $242.8M |
负债/权益比FMSQIPT
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.9B | $8.9M |
| 自由现金流经营现金流 - 资本支出 | — | $6.9M |
| 自由现金流率自由现金流/营收 | — | 14.0% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | 6.67× | — |
| 过去12个月自由现金流最近4个季度 | — | $26.6M |
8季度趋势，按日历期对齐
经营现金流FMSQIPT
| Q4 25 | $2.9B | $8.9M | ||
| Q3 25 | — | $9.8M | ||
| Q2 25 | — | $9.7M | ||
| Q1 25 | — | $8.9M | ||
| Q4 24 | $2.6B | $9.3M |
自由现金流FMSQIPT
| Q4 25 | — | $6.9M | ||
| Q3 25 | — | $8.0M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $7.3M | ||
| Q4 24 | — | $5.6M |
自由现金流率FMSQIPT
| Q4 25 | — | 14.0% | ||
| Q3 25 | — | 20.0% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 15.2% |
资本支出强度FMSQIPT
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 14.9% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 9.9% |
现金转化率FMSQIPT
| Q4 25 | 6.67× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 20.20× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
